Mark Flory

Staff Scientist

  • 1370 Citations
  • 14 h-Index
19962017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mark Flory is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Proteomics Medicine & Life Sciences
Centrosome Medicine & Life Sciences
Proteins Medicine & Life Sciences
Schizosaccharomyces Medicine & Life Sciences
Spindle Pole Bodies Medicine & Life Sciences
Mass Spectrometry Medicine & Life Sciences
Isotopes Medicine & Life Sciences
Calmodulin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2017

  • 1370 Citations
  • 14 h-Index
  • 19 Article
  • 2 Review article
  • 1 Chapter
1 Citation (Scopus)

A robust protocol for protein extraction and digestion

Atallah, M., Flory, M. & Mallick, P., Jan 1 2017, Methods in Molecular Biology. Humana Press Inc., p. 1-10 10 p. (Methods in Molecular Biology; vol. 1550).

Research output: Chapter in Book/Report/Conference proceedingChapter

Proteolysis
Proteomics
Proteins
Mass Spectrometry
Biological Phenomena
14 Citations (Scopus)

A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies

Kim, S. Y., Theunissen, J. W., Balibalos, J., Liao-Chan, S., Babcock, M. C., Wong, T., Cairns, B., Gonzalez, D., Van Der Horst, E. H., Perez, M., Levashova, Z., Chinn, L., D'Alessio, J. A., Flory, M., Bermudez, A., Jackson, D. Y., Ha, E., Monteon, J., Bruhns, M. F., Chen, G. & 1 others, Migone, T. S., May 29 2015, In : Blood cancer journal. 5, 5, e316.

Research output: Contribution to journalArticle

Open Access
Hematologic Neoplasms
Drug Delivery Systems
Surface Antigens
Acute Myeloid Leukemia
Leukemia
56 Citations (Scopus)

Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs

Behrens, C. R., Ha, E. H., Chinn, L. L., Bowers, S., Probst, G., Fitch-Bruhns, M., Monteon, J., Valdiosera, A., Bermudez, A., Liao-Chan, S., Wong, T., Melnick, J., Theunissen, J. W., Flory, M., Houser, D., Venstrom, K., Levashova, Z., Sauer, P., Migone, T. S., Van Der Horst, E. H. & 2 others, Halcomb, R. L. & Jackson, D. Y., Nov 2 2015, In : Molecular Pharmaceutics. 12, 11, p. 3986-3998 13 p.

Research output: Contribution to journalArticle

Cysteine
Pharmacology
Antibodies
Pharmaceutical Preparations

CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma

Hayes, G. M., Cairns, B., Levashova, Z., Chinn, L., Perez, M., Theunissen, J. W., Liao-Chan, S., Bermudez, A., Flory, M., Schweighofer, K. J. & van der Horst, E. H., Jan 1 2015, In : American Journal of Translational Research. 7, 6, p. 1181-1188 8 p.

Research output: Contribution to journalArticle

Sarcoma
nucleotidase
Tissue
Antibodies
Tumors
9 Citations (Scopus)

Ccq1p and the condensin proteins Cut3p and Cut14p prevent telomere entanglements in the fission yeast Schizosaccharomyces pombe

Motwani, T., Doris, R., Holmes, S. G. & Flory, M., Oct 1 2010, In : Eukaryotic Cell. 9, 10, p. 1612-1621 10 p.

Research output: Contribution to journalArticle

Open Access
Schizosaccharomyces
Telomere
Proteins
Cluster Analysis
Chromosome Segregation